Skip to main content
Premium Trial:

Request an Annual Quote

Inova to Use GenoSpace Platform for Whole-Genome Sequencing Project

NEW YORK (GenomeWeb) –Inova Health System, a not-for-profit healthcare system in Washington, DC, will use GenoSpace's Population Analytics platform to analyze and explore clinical and genomic data from an ongoing whole-genome sequencing initiative, GenoSpace said today.

Greg Eley, chief technology officer of the Inova Translational Medicine Institute, a division of the larger Inova system, said in a statement that Inova selected GenoSpace's product because of its analytical capabilities and the company's experience serving customers in R&D and clinical care.

To date, the ITMI has sequenced more than 8,000 genomes from individuals representing more than 100 countries and expects to have sequenced roughly 20,000 genomes by the end of 2015. These sequences have been linked to extensive clinical data with the goal of discovering genetic factors contributing to a wide range of diseases.

"We needed an effective solution to the challenge of making petabytes of genomic data accessible to the scientists and physicians in our organization," Eley said.  GenoSpace's platform provides the tools needed by Inova staff "to efficiently gain insight from large quantities of complex information."

The Scan

Not as High as Hoped

The Associated Press says initial results from a trial of CureVac's SARS-CoV-2 vaccine suggests low effectiveness in preventing COVID-19.

Finding Freshwater DNA

A new research project plans to use eDNA sampling to analyze freshwater rivers across the world, the Guardian reports.

Rise in Payments

Kaiser Health News investigates the rise of payments made by medical device companies to surgeons that could be in violation of anti-kickback laws.

Nature Papers Present Ginkgo Biloba Genome Assembly, Collection of Polygenic Indexes, More

In Nature this week: a nearly complete Ginkgo biloba genome assembly, polygenic indexes for dozens of phenotypes, and more.